Chinese guidelines for treatment of adult primary immune thrombocytopenia

Xin-Guang Liu¹, Xiao-Chuan Bai², Fang-Ping Chen³, Yun-Feng Cheng⁴, Ke-Sheng Dai⁵, Mei-Yun Fang⁶, Jian-Ming Feng⁷, Yu-Ping Gong⁸, Tao Guo⁹, Xin-Hong Guo¹⁰, Yue Han⁵, Luo-Jia Hong¹¹, Yu Hu⁹, Bao-Lai Hua¹², Rui-Bing Huang¹³, Yan Li¹⁴, Jun Peng¹, Mi-Mi Shu¹⁵, Jing Sun¹⁶, Pei-Yan Sun¹⁷, Yu-Qian Sun¹⁸, Chun-Sen Wang¹⁹, Shu-Jie Wang²⁰, Xiao-Min Wang²¹, Cong-Ming Wu²², Wen-Man Wu²³, Zhen-Yu Yan²⁴, Feng-E Yang²⁵, Lin-Hua Yang²⁶, Ren-Chi Yang²⁷, Tong-Hua Yang²⁸, Xu Ye²⁹, Guang-Sen Zhang³⁰, Lei Zhang²⁷, Chang-Cheng Zheng³¹, Hu Zhou³², Min Zhou³³, Rong-Fu Zhou³⁴, Ze-Ping Zhou³⁵, Hong-Li Zhu³⁶, Tie-Nan Zhu²⁰, Ming Hou³⁷

Affiliations

¹ Department of Hematology, Qilu Hospital, Shandong University, Jinan, 250012, China.
² General Hospital of Ningxia Medical University, Yinchuan, China.
³ Xiangya Hospital, Centre South University, Changsha, China.
⁴ Zhongshan Hospital, Fudan University, Shanghai, China.
⁵ The First Affiliated Hospital of Soochow University, Suzhou, China.
⁶ The First Affiliated Hospital of Dalian Medical University, Dalian, China.
⁷ Qinghai Provincial People's Hospital, Xining, China.
⁸ West China Hospital, Sichuan University, Chengdu, China.
⁹ Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
¹⁰ The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
¹¹ Harbin the Fourth Hospital, Harbin, China.
¹² Northern Jiangsu People's Hospital, Yangzhou, China.
¹³ The First Affiliated Hospital of Nanchang University, Nanchang, China.
¹⁴ The First Hospital of Chinese Medical University, Shenyang, China.
¹⁵ Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
¹⁶ Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
¹⁷ Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
¹⁸ Peking University People's Hospital, Beijing, China.
¹⁹ Sichuan Provincial People's Hospital, Chengdu, China.
²⁰ Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
²¹ People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China.
²² Hainan Provincial People's Hospital, Haikou, China.
²³ Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.
²⁴ Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
²⁵ Union Hospital of Fujian Medical University, Fuzhou, China.
²⁶ The Second Hospital of Shanxi Medical University, Taiyuan, China.
²⁷ Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.
²⁸ The First People's Hospital of Yunnan Province, Kunming, China.
²⁹ The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
³⁰ The Second Xiangya Hospital, Central South University, Changsha, China.
³¹ Anhui Provincial Hospital, Hefei, China.
³² Henan Cancer Hospital, Zhengzhou, China.
³³ Chengdu Women and Children's Hospital, Chengdu, China.
³⁴ Nanjing Drum Tower Hospital, Nanjing, China.
³⁵ The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
³⁶ Chinese PLA General Hospital, Beijing, China.
³⁷ Department of Hematology, Qilu Hospital, Shandong University, Jinan, 250012, China. houming@medmail.com.cn.

PMID: 29619624
DOI: 10.1007/s12185-018-2445-z

Review

Chinese guidelines for treatment of adult primary immune thrombocytopenia

Xin-Guang Liu et al. Int J Hematol. 2018 Jun.

. 2018 Jun;107(6):615-623.

doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.

Authors

Affiliations

¹ Department of Hematology, Qilu Hospital, Shandong University, Jinan, 250012, China.
² General Hospital of Ningxia Medical University, Yinchuan, China.
³ Xiangya Hospital, Centre South University, Changsha, China.
⁴ Zhongshan Hospital, Fudan University, Shanghai, China.
⁵ The First Affiliated Hospital of Soochow University, Suzhou, China.
⁶ The First Affiliated Hospital of Dalian Medical University, Dalian, China.
⁷ Qinghai Provincial People's Hospital, Xining, China.
⁸ West China Hospital, Sichuan University, Chengdu, China.
⁹ Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
¹⁰ The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
¹¹ Harbin the Fourth Hospital, Harbin, China.
¹² Northern Jiangsu People's Hospital, Yangzhou, China.
¹³ The First Affiliated Hospital of Nanchang University, Nanchang, China.
¹⁴ The First Hospital of Chinese Medical University, Shenyang, China.
¹⁵ Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
¹⁶ Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
¹⁷ Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
¹⁸ Peking University People's Hospital, Beijing, China.
¹⁹ Sichuan Provincial People's Hospital, Chengdu, China.
²⁰ Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
²¹ People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China.
²² Hainan Provincial People's Hospital, Haikou, China.
²³ Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.
²⁴ Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
²⁵ Union Hospital of Fujian Medical University, Fuzhou, China.
²⁶ The Second Hospital of Shanxi Medical University, Taiyuan, China.
²⁷ Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.
²⁸ The First People's Hospital of Yunnan Province, Kunming, China.
²⁹ The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
³⁰ The Second Xiangya Hospital, Central South University, Changsha, China.
³¹ Anhui Provincial Hospital, Hefei, China.
³² Henan Cancer Hospital, Zhengzhou, China.
³³ Chengdu Women and Children's Hospital, Chengdu, China.
³⁴ Nanjing Drum Tower Hospital, Nanjing, China.
³⁵ The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
³⁶ Chinese PLA General Hospital, Beijing, China.
³⁷ Department of Hematology, Qilu Hospital, Shandong University, Jinan, 250012, China. houming@medmail.com.cn.

PMID: 29619624
DOI: 10.1007/s12185-018-2445-z

Abstract

Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria, bleeding assessment, diagnosis, and management of ITP. The Chinese consensus reports for diagnosis and management of adult ITP have been updated to the 4th edition. Based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the Chinese Society of Hematology issued Chinese guidelines for management of adult ITP, which aim to provide evidence-based recommendations for clinical decision making.

Keywords: Diagnosis, management; Guideline; Primary immune thrombocytopenia.

PubMed Disclaimer

References

1. Blood. 2012 Feb 9;119(6):1356-62 - PubMed
1. Blood. 1984 Dec;64(6):1179-83 - PubMed
1. Ann Hematol. 2009 Jan;88(1):11-5 - PubMed
1. Acta Haematol. 1994;91(1):1-6 - PubMed
1. Blood. 2016 Jan 21;127(3):296-302; quiz 370 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Chinese guidelines for treatment of adult primary immune thrombocytopenia

Affiliations

Chinese guidelines for treatment of adult primary immune thrombocytopenia

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical